Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 5, 2010, Pages 548-555

  Guerrerio, Anthony L ^a   Frischmeyer Guerrerio, Pamela A ^a   Lederman, Howard M ^a   Oliva Hemker, Maria ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gastrointestinal; hepatic; histology; immunodeficiency; pediatric

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A;

BIOPSY; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE COURSE; ENTERITIS; ENTEROPATHY; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOTHERAPY; IPEX SYNDROME; MALABSORPTION; POLYENDOCRINOPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST; TREATMENT RESPONSE; WISKOTT ALDRICH SYNDROME;

CHILD; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIVER DISEASES;

EID: 78149261559     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181efe56b     Document Type: Review

References (107)

1. Notarangelo LD, Fischer A, Geha RS, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009;124:1161-78.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
3. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008;46: 1547-54.
4. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007;27:308-16.
5. Aghamohammadi A, Farhoudi A, Moin M, et al. Clinical and im-munological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12:825-32.
6. Aydogan M, Eifan AO, Gocmen I, et al. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications. J Investig Allergol Clin Immunol 2008; 18:260-5.
7. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol 2001;21:145-9.
8. Llobet MP, Soler-Palacin P, Detkova D, et al. Common variable immunodeficiency: 20-year experience at a single centre. Pediatr Allergy Immunol 2009;20:113-8.
9. Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007;31:1800-12.
10. Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52:2977-83.
11. Luzi G, Zullo A, Iebba F, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol 2003;98:118-21.
12. Washington K, Stenzel TT, Buckley RH, et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 1996;20:1240-52.
13. Zullo A, Romiti A, Rinaldi V, et al. Gastric pathology in patients with common variable immunodeficiency. Gut 1999;45:77-81.
14. Kersey JH, Spector BD, Good RA. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer 1973;12:333-47.
15. Mellemkjaer L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002;130:495-500.
16. Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late-onset immu-noglobulin deficiency. Clinical observations in 50 patients. Am J Med 1976;61:221-37.
17. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86:31-42.
18. Kinlen LJ, Webster AD, Bird AG, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985;1:263-6.
19. Daniels JA, Torbenson M, Vivekanandan P, et al. Hepatitis in common variable immunodeficiency. Hum Pathol 2009;40:484-8.
20. Gompels MM, Hodges E, Lock RJ, et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 2003; 134:314-20.
21. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001;21:303-9.
22. Janzi M, Kull I, Sjoberg R, et al. Selective IgA deficiency in early life: association to infections and allergic diseases during childhood. Clin Immunol 2009;133:78-85.
23. Morell A, Muehlheim E, Schaad U, et al. Susceptibility to infections in children with selective IgA-and IgA-IgG subclass deficiency. Eur J Pediatr 1986;145:199-203.
24. Savilahti E, Pelkonen P, Visakorpi JK. IgA deficiency in children. A clinical study with special reference to intestinal findings. Arch Dis Child 1971;46:665-70.
25. Ammann AJ, Hong R. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) 1971;50: 223-36.
26. Hayakawa H, Iwata T, Yata J, et al. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol 1981;1:31-9.
27. Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979. J Clin Immunol 1982;2:86-92.
28. Luzi G, Businco L, Aiuti F. Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol 1983;3:316-20.
29. Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol 1988;8:479-85.
30. Aghamohammadi A, Cheraghi T, Gharagozlou M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol 2009;29:130-6.
31. De Laat PC, Weemaes CM, Gonera R, et al. Clinical manifestations in selective IgA deficiency in childhood. A follow-up report. Acta Paediatr Scand 1991;80:798-804.
32. Ugazio AG, Out TA, Plebani A, et al. Recurrent infections in children with "selective" IgA deficiency: association with IgG2 and IgG4 deficiency. Birth Defects Orig Artic Ser 1983;19:169-71.
33. Burgio GR, Duse M, Monafo V, et al. Selective IgA deficiency: clinical and immunological evaluation of 50 pediatric patients. Eur J Pediatr 1980;133:101-6.
34. Buckley RH, Dees SC. Correlation of milk precipitins with IgA deficiency. N Engl J Med 1969;281:465-9.
35. Gupta R, Sheikh A, Strachan DP, et al. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34:520-6.
36. Grundbacher FJ, Massie FS. Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals. J Allergy Clin Immunol 1985;75:651-8.
37. Plebani A, Monafo V, Ugazio AG, et al. Comparison of the frequency of atopic diseases in children with severe and partial IgA deficiency. Int Arch Allergy Appl Immunol 1987;82:485-6.
38. Cassidy JT, Burt A. Selective hypogammaglobulinemia in rheumatoid arthritis. Univ Mich Med Cent J 1968:241-243.
39. Alarcon-Segovia D, Fishbein E. Serum immunoglobulins in systemic lupus erythematosus. Clin Sci 1972;43:121-31.
40. Yewdall V, Cameron JS, Nathan AW, et al. Systemic lupus erythema-tosus and IgA deficiency. J Clin Lab Immunol 1983;10:13-8.
41. Rifle G, Bielefeld P, Chalopin JM, et al. Selective IgA deficiency and systemic lupus erythematosus. Ann Med Interne (Paris) 1988;139: 134-7.
42. Gershwin ME, Blaese RM, Steinberg AD, et al. Antibodies to nucleic acids in congenital immune deficiency states. J Pediatr 1976;89: 377-81.
43. Bluestone R, Goldberg LS, Katz RM, et al. Juvenile rheumatoid arthritis\a serologic survey of 200 consecutive patients. J Pediatr 1970;77:98-102.
44. Panush RS, Bianco NE, Schur PH, et al. Juvenile rheumatoid arthritis. Cellularhypersensitivity and selective IgA deficiency. Clin Exp Immunol 1972;10:103-15.
45. Salmi TT, Schmidt E, Laaksonen AL, et al. Levels of serum immu-noglobulins in juvenile rheumatoid arthritis. Ann Clin Res 1973; 5:395-7.
46. Barkley DO, Hohermuth HJ, Howard A, et al. IgA deficiency in juvenile chronic polyarthritis. J Rheumatol 1979;6:219-24.
47. Pelkonen P, Savilahti E, Makela AL. Persistent and transient IgA deficiency in juvenile rheumatoid arthritis. Scand J Rheumatol 1983; 12:273-9.
48. Natvig JB, Harboe M, Fausa O, et al. Family studies in individuals with selective absence of gamma-A-globulin. Clin Exp Immunol 1971; 8:229-36.
49. Cataldo F, Marino V, Bottaro G, et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997;131:306-8.
50. Heneghan MA, Stevens FM, Cryan EM, et al. Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol 1997;25:421-5.
51. McGowan KE, Lyon ME, Butzner JD. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem 2008;54:1203-9.
52. Korponay-Szabo IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 2003;52: 1567-71.
53. Klemola T. Deficiency of immunoglobulin A. Ann Clin Res 1987;19: 248-57.
54. Klemola T. Immunohistochemical findings in the intestine of IgA-deficient persons: number of intraepithelial T lymphocytes is increased. J Pediatr Gastroenterol Nutr 1988;7:537-43.
55. Meini A, Pillan NM, Villanacci V, et al. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann Allergy Asthma Immunol 1996;77:333-6.
56. Kumar V, Jarzabek-Chorzelska M, Sulej J, et al. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol 2002;9:1295-300.
57. Aghamohammadi A, Mohammadi J, Parvaneh N, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008;147:87-92.
58. Carvalho Neves Forte W, Ferreira De Carvalho Junior F, Damaceno N, et al. Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency. Allergol Immunopathol (Madr) 2000;28:18-20.
59. Espanol T, Catala M, Hernandez M, et al. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 1996;80:333-5.
60. Gutierrez MG, Kirkpatrick CH. Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol 1997;79: 297-301.
61. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190-7.
62. Winkelstein JA, Marino MC, Johnston RB Jr et al. Chronic granu-lomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-69.
63. Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 1957; 40:309-12.
64. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 1959;97:387-408.
65. Van Den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulo-matous disease: the European experience. PLoS One 2009;4:e5234.
66. Ahlin A, De Boer M, Roos D, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995;84:1386-94.
67. Kobayashi S, Murayama S, Takanashi S, et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr 2008;167: 1389-94.
68. Liese J, Kloos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000;137:687-93.
69. Martire B, Rondelli R, Soresina A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 2008;126:155-64.
70. Soler-Palacin P, Margareto C, Llobet P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immu-nopathol (Madr) 2007;35:83-9.
71. Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol 2008;129:103-14.
72. Jones LB, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 2008; 152:211-8.
73. Marks DJ, Miyagi K, Rahman FZ, et al. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol 2009;104:117-24.
74. Hussain N, Feld JJ, Kleiner DE, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007;45: 675-83.
75. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-44.
76. Wiskott A. Familiarer, angeborener Morbus Werlhofii? Monatsschr Kiderheilkd 1937;68:212-6.
77. Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 1954;13: 133-9.
78. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006;117:725-38.
79. Perry GS 3rd, Spector BD, Schuman LM, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr 1980;97:72-8.
80. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 2003;111:e622-7.
81. Sullivan KE, Mullen CA, Blaese RM, et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994;125:876-85.
82. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4\+CD25\+ regulatory T cells. Nat Immunol 2003;4:330-6.
83. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
84. Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4\+CD25\+ T regulatory cells. Nat Immunol 2003;4:337-42.
85. Schubert LA, Jeffery E, Zhang Y, et al. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001;276:37672-9.
86. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-1.
87. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18-20.
88. Chatila TA, Blaeser F, Ho N, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106:R75-81.
89. D'Hennezel E, Ben-Shoshan M, Ochs HD, et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 2009;361:1710-3.
90. Gambineri E, Perroni L, Passerini L, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, poly-endocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008;122:1105.
91. Ferguson PJ, Blanton SH, Saulsbury FT, et al. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet 2000;90:390-7.
92. Kobayashi I, Shiari R, Yamada M, et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet 2001;38: 874-6.
93. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982;100: 731-7.
94. McGinness JL, Bivens MM, Greer KE, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 2006;55:143-8.
95. Costa-Carvalho BT, de Moraes-Pinto MI, de Almeida LC, et al. A remarkable depletion of both naive CD4\+ and CD8\+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain. Scand J Immunol 2008;68:85-91.
96. Levy-Lahad E, Wildin RS. Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: further evidence for an X-linked lethal syndrome. J Pediatr 2001;138:577-80.
97. Peake JE, McCrossin RB, Byrne G, et al. X-linked immune dysregula-tion, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child Fetal Neonatal Ed 1996;74:F195-9.
98. Myers AK, Perroni L, Costigan C, et al. Clinical and molecular findings in IPEX syndrome. Arch Dis Child 2006;91:63-4.
99. Baud O, Goulet O, Canioni D, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001;344:1758-62.
100. Bindl L, Torgerson T, Perroni L, et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, poly-endocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005;147: 256-9.
101. Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, entero-pathy, X-linked syndrome (IPEX). Clin Exp Immunol 2004;137:373-8.
102. Nieves DS, Phipps RP, Pollock SJ, et al. Dermatologic and im-munologic findings in the immune dysregulation, polyendocrino-pathy, enteropathy, X-linked syndrome. Arch Dermatol 2004;140: 466-72.
103. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39: 537-45.
104. Redding AR, Lew DB, Conley ME, et al. An infant with erythroderma, skin scaling, chronic emesis, and intractable diarrhea. Clin Pediatr (Phila) 2009;48:978-80.
105. Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 2007;132:1705-17.
106. Patey-Mariaud de Serre N, Canioni D, Ganousse S, et al. Digestive histopathological presentation of IPEX syndrome. Mod Pathol 2009; 22:95-102.
107. Frischmeyer-Guerrerio PA, Wisniewski J, Wood RA, et al. Manifestations and long-term outcome of food allergy in children after solid organ transplantation. J Allergy Clin Immunol 2008;122:1031 e1-3.